Palliative management of gastric cancer

Steven C. Cunningham, Richard D. Schulick

Research output: Contribution to journalArticle

Abstract

Advanced gastric cancer and its palliative treatment have a long and interesting history. Today, gastric adenocarcinoma is the second leading cause of cancer death worldwide. Unfortunately, many cases are not diagnosed until late stages of disease, which underscores the importance of the palliative treatment of gastric cancer. Palliative care is best defined as the active total care of patients whose disease is not responsive to curative treatment. Although endoscopy is the most useful method for securing the diagnosis of gastric adenocarcinoma, computed tomography may be useful to assess local and distant disease. The main indication for the institution of palliative care is the presence of advanced gastric cancer for which curative treatment is deemed inappropriate. The primary goal of palliative therapy of gastric cancer patients is to improve quality, not necessarily length, of life. Four main modalities of palliative therapy for advanced gastric cancer are discussed: resection, bypass, stenting, and chemotherapy. The choice of modality depends on a variety of factors, including individual patient prognosis and goals, and should be made on case-by-case basis. Future directions include the discovery and development of serum or stool tumor markers aimed at prevention, improving prognostication and stratification, and increasing awareness and education.

Original languageEnglish (US)
Pages (from-to)267-275
Number of pages9
JournalSurgical Oncology
Volume16
Issue number4
DOIs
StatePublished - Dec 2007

Fingerprint

Palliative Care
Stomach Neoplasms
Stomach
Adenocarcinoma
Tumor Biomarkers
Endoscopy
Cause of Death
Patient Care
History
Tomography
Education
Drug Therapy
Therapeutics
Serum
Neoplasms

Keywords

  • Gastric cancer
  • Palliation

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Palliative management of gastric cancer. / Cunningham, Steven C.; Schulick, Richard D.

In: Surgical Oncology, Vol. 16, No. 4, 12.2007, p. 267-275.

Research output: Contribution to journalArticle

Cunningham, SC & Schulick, RD 2007, 'Palliative management of gastric cancer', Surgical Oncology, vol. 16, no. 4, pp. 267-275. https://doi.org/10.1016/j.suronc.2007.08.004
Cunningham, Steven C. ; Schulick, Richard D. / Palliative management of gastric cancer. In: Surgical Oncology. 2007 ; Vol. 16, No. 4. pp. 267-275.
@article{03755aa831a449a2a0714cee2af081bb,
title = "Palliative management of gastric cancer",
abstract = "Advanced gastric cancer and its palliative treatment have a long and interesting history. Today, gastric adenocarcinoma is the second leading cause of cancer death worldwide. Unfortunately, many cases are not diagnosed until late stages of disease, which underscores the importance of the palliative treatment of gastric cancer. Palliative care is best defined as the active total care of patients whose disease is not responsive to curative treatment. Although endoscopy is the most useful method for securing the diagnosis of gastric adenocarcinoma, computed tomography may be useful to assess local and distant disease. The main indication for the institution of palliative care is the presence of advanced gastric cancer for which curative treatment is deemed inappropriate. The primary goal of palliative therapy of gastric cancer patients is to improve quality, not necessarily length, of life. Four main modalities of palliative therapy for advanced gastric cancer are discussed: resection, bypass, stenting, and chemotherapy. The choice of modality depends on a variety of factors, including individual patient prognosis and goals, and should be made on case-by-case basis. Future directions include the discovery and development of serum or stool tumor markers aimed at prevention, improving prognostication and stratification, and increasing awareness and education.",
keywords = "Gastric cancer, Palliation",
author = "Cunningham, {Steven C.} and Schulick, {Richard D.}",
year = "2007",
month = "12",
doi = "10.1016/j.suronc.2007.08.004",
language = "English (US)",
volume = "16",
pages = "267--275",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Palliative management of gastric cancer

AU - Cunningham, Steven C.

AU - Schulick, Richard D.

PY - 2007/12

Y1 - 2007/12

N2 - Advanced gastric cancer and its palliative treatment have a long and interesting history. Today, gastric adenocarcinoma is the second leading cause of cancer death worldwide. Unfortunately, many cases are not diagnosed until late stages of disease, which underscores the importance of the palliative treatment of gastric cancer. Palliative care is best defined as the active total care of patients whose disease is not responsive to curative treatment. Although endoscopy is the most useful method for securing the diagnosis of gastric adenocarcinoma, computed tomography may be useful to assess local and distant disease. The main indication for the institution of palliative care is the presence of advanced gastric cancer for which curative treatment is deemed inappropriate. The primary goal of palliative therapy of gastric cancer patients is to improve quality, not necessarily length, of life. Four main modalities of palliative therapy for advanced gastric cancer are discussed: resection, bypass, stenting, and chemotherapy. The choice of modality depends on a variety of factors, including individual patient prognosis and goals, and should be made on case-by-case basis. Future directions include the discovery and development of serum or stool tumor markers aimed at prevention, improving prognostication and stratification, and increasing awareness and education.

AB - Advanced gastric cancer and its palliative treatment have a long and interesting history. Today, gastric adenocarcinoma is the second leading cause of cancer death worldwide. Unfortunately, many cases are not diagnosed until late stages of disease, which underscores the importance of the palliative treatment of gastric cancer. Palliative care is best defined as the active total care of patients whose disease is not responsive to curative treatment. Although endoscopy is the most useful method for securing the diagnosis of gastric adenocarcinoma, computed tomography may be useful to assess local and distant disease. The main indication for the institution of palliative care is the presence of advanced gastric cancer for which curative treatment is deemed inappropriate. The primary goal of palliative therapy of gastric cancer patients is to improve quality, not necessarily length, of life. Four main modalities of palliative therapy for advanced gastric cancer are discussed: resection, bypass, stenting, and chemotherapy. The choice of modality depends on a variety of factors, including individual patient prognosis and goals, and should be made on case-by-case basis. Future directions include the discovery and development of serum or stool tumor markers aimed at prevention, improving prognostication and stratification, and increasing awareness and education.

KW - Gastric cancer

KW - Palliation

UR - http://www.scopus.com/inward/record.url?scp=36549074089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549074089&partnerID=8YFLogxK

U2 - 10.1016/j.suronc.2007.08.004

DO - 10.1016/j.suronc.2007.08.004

M3 - Article

C2 - 17881220

AN - SCOPUS:36549074089

VL - 16

SP - 267

EP - 275

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 4

ER -